Our 6 product segments
Drug Substances (API) / Drug Products (FDF) / Cultivated / Cultured Meat / Immune / Cell Therapy / Bioprocessing / Technologies /
Drug Substances (API) / Drug Products (FDF) / Cultivated / Cultured Meat / Immune / Cell Therapy / Bioprocessing / Technologies /
Pharma/Biotech Industry - Fragmented Data, Lacking Connections between all relevant data sets.
Whether you are a big pharma or a small biotech company, start-up, distributor of pharmaceuticals, or even a government health organization, you have probably hit a wall when it comes to accessing unique API or reagents, key proteins (plasma-derived or recombinant), biosimilars, in-license technologies, drugs (FDF), or even new distributors.
It’s a massive investment of time, effort and resources, requires a skilled team, subscriptions on various databases which cost up to tens of thousands of USD annually, attending conferences, using analysts and consultants to source the products you need.
Sometimes, even after all these sources/tools, you find yourself with no match to the manufacturer/supplier/products you were looking for.
The biggest challenge is that Pharma Industry is fragmented. There is no one source that aggregates all pharma industry companies and products in one place, or a database of all patents and clinical trials, not to mention the connections between these data sets. This is most acutely felt with biosimilars, vaccines and various injectable drugs. These days, we face another challenge due to the COVID19 pandemic which makes it more difficult to attend exhibitions and conferences to explore our needs.
Every delay in sourcing can lead to millions of dollars in lost revenue. It’s time to free up this bottleneck.
Various companies offer subscriptions to various databases, but none cover all.
Bio-Lead - Faster Sourcing to Maximize Business Potential
Bio-Lead has the ability to source a wide range of APIs, (Active Pharmaceutical Ingredients), Drug Products (licenses), Reagents, GMP and non-GMP Proteins (recombinant or Plasma derived) and technologies for faster go to market and portfolio expansion, while gaining and maintaining a competitive edge.
We serve a variety of industries:
Bio-Lead - The Bridge Between Seekers, Innovators and Drug Manufacturers
Bio-Lead blends the best in human intelligence with cutting edge technology:
By mapping the entire pharma industry, we are able to generate smart outcomes and expose business opportunities.
Pharma/Biotech Industry - Fragmented Data, Lacking Connections between all relevant data sets.
Whether you are a big pharma or a small biotech company, start-up, distributor of pharmaceuticals, or even a government health organization, you have probably hit a wall when it comes to accessing unique API or reagents, key proteins (plasma-derived or recombinant), biosimilars, in-license technologies, drugs (FDF), or even new distributors.
It’s a massive investment of time, effort and resources, requires a skilled team, subscriptions on various databases which cost up to tens of thousands of USD annually, attending conferences, using analysts and consultants to source the products you need.
Sometimes, even after all these sources/tools, you find yourself with no match to the manufacturer/supplier/products you were looking for.
The biggest challenge is that Pharma Industry is fragmented. There is no one source that aggregates all pharma industry companies and products in one place, or a database of all patents and clinical trials, not to mention the connections between these data sets. This is most acutely felt with biosimilars, vaccines and various injectable drugs. These days, we face another challenge due to the COVID19 pandemic which makes it more difficult to attend exhibitions and conferences to explore our needs.
Every delay in sourcing can lead to millions of dollars in lost revenue. It’s time to free up this bottleneck.
Various companies offer subscriptions to various databases, but none cover all.
Bio-Lead - Faster Sourcing to Maximize Business Potential
Bio-Lead has the ability to source a wide range of APIs, (Active Pharmaceutical Ingredients), Drug Products (licenses), Reagents, GMP and non-GMP Proteins (recombinant or Plasma derived) and technologies for faster go to market and portfolio expansion, while gaining and maintaining a competitive edge.
We serve a variety of industries:
Bio-Lead - The Bridge Between Seekers, Innovators and Drug Manufacturers
Bio-Lead blends the best in human intelligence with cutting edge technology:
By mapping the entire pharma industry, we are able to generate smart outcomes and expose business opportunities.
We turned the world upside down bringing you the right solution at the most affordable price, to support your endeavor towards a clean meat product.
The hottest buss word is AG-Farming (agricultural farming / cellular agriculture) with its related segments – cultivated-meat, fermentation-enabled proteins and plant-based proteins.
More from GFI –
This is true, one of the most challenging bottlenecks of this industry, so if you are a cultivated-meat or fermentation-enabled proteins company, facing a challenge in reducing the cost of your cell culture media and supplements as well as growth factors, we are here to make a change for you.
With over 20 years of experience in all aspects of recombinant proteins and cell culture media, from production to business we are sure we will be able to assist your company as well. Serving tens of thousands of clients in all segments of cell-based applications.
Reagents and recombinant proteins Industry - Fragmented Data, Lacking Connections between all relevant data sets.
FGF2, Insulin, EPO, TGF-beta, Transferrin, rhAlbumin or others ?
Whether you are a big pharma or a small biotech company or even a government health organization, dealing in the field of Cell/Immune Therapy, you have probably hit a wall when it comes to accessing unique protein reagents, such as key recombinant proteins and growth factors, whether GMP or non-GMP grade.
The biggest challenge is that the iindustry is fragmented. There is no one source that aggregates all industry companies and products in one place, not to mention the connections between these data sets. This is most acutely felt with some key GMP grade growth factors. These days, we face another challenge due to the COVID19 pandemic which makes it more difficult to attend exhibitions and conferences to explore our needs.
Every delay in sourcing can lead to millions of dollars in lost revenue. It’s time to free up this bottleneck.
Bio-Lead - Faster Sourcing to Maximize your endeavor towards Cell/Immune therapy products.
Bio-Lead has the ability to source a wide range of APIs, (Active Pharmaceutical Ingredients), Drug GMP and non-GMP Proteins (recombinant or Plasma derived) and technologies for faster go to market and portfolio expansion, while gaining and maintaining a competitive edge.
Due to our activity in the biopharma industry, we are capable of supplying few GMP grade growth factors in 50%-75% less than their common market price.
Contact us today!
Single-use bags, Reagents, Cell Culture Media and Recombinant proteins Industry - Fragmented Data, Lacking Connections between all relevant data sets.
FGF2, Insulin, EPO, LR3-IGF-1, EGF, Transferrin, rhAlbumin or whether CHO or VERO cells media?
Whether you are a big pharma or a small biotech company or even a government health organization, dealing in the production of biologics, you have probably hit a wall when it comes to accessing unique products, such as key GMP grade recombinant growth factors, single-use bags or specialty cell-culture media.
The biggest challenge is that the Industry is fragmented. There is no one source that aggregates all industry companies and products in one place, not to mention the connections between these data sets.
These days, we face another challenge due to the COVID19 pandemic which makes it more difficult to attend exhibitions and conferences to explore your needs. The pandemic also created significant shortages in the supply of single-use bags.
Every delay in sourcing can lead to millions of dollars in lost revenue. It’s time to free up this bottleneck.
Bio-Lead - Faster Sourcing to Maximize your endeavor towards Cell/Immune therapy products.
Bio-Lead has the ability to source a wide range of APIs, (Active Pharmaceutical Ingredients), GMP and non-GMP Proteins (recombinant or Plasma-derived), Single-use bags and technologies for faster go to market and portfolio expansion, while gaining and maintaining a competitive edge.
Contact us today!
Bio-Lead The bridge between seekers, Innovators and Drug Manufacturers
All about us
Led by Mr. Offir Manor, a biotechnology engineer with over 20 years of experience in the field of recombinant proteins development and production as well as cell culture media products.
After 10 years on the bench, developing production processes and manufacturing these products, he made a shift to the business side. International business development and management of multi-million-dollar budgets in biological reagents and pharmaceutical/biotech industries with special expertise of managing multiple number of distributors and all aspects of distribution, globally.
Through all these years, he has been built step by step, a very large network of strong business connections with leading manufacturers from all over the world. The company has since evolved to build a significant and smart algorithm-based database, enables to target almost any product in the field. Over the years we have assisted a variety of companies locate the same critical component for their operations.We are getting better all the time!
Today, the main focus is on the Cultured-meat Industry that has evolved, at least partially from stem cell research as well as developments in the cell therapy industry. He served these industries for many years, knowing any aspects of their needs. After these years he was looking to find a more meaningful path while still using all the knowledge and skills he has accumulated. The Cultured-Meat industry was a natural and obvious choice. This is his way to join the movement of changing the way people consume food. Holding the hope to harness his capabilities to bring the cultured-meat industry faster to a price parity with animal farming which is far from being efficient and causes a lot of suffer.
Case Studies
Testimonials